(Q34775243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Saliva and inhibition of HIV-1 infection: molecular mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Stephen Challacombe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

D C Shugars

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S P Sweet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S H Kazmi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

K Page-Shafer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

8 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

169-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

HIV infected women and genital health

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Salivary and mucosal immune responses to HIV and its co-pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Neopterin and β2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Submandibular salivary proteases: lack of a role in anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

The effect of route of immunization on mucosal immunity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Advances and research directions in the prevention of mother-to-child HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Human Submandibular Saliva Specifically Inhibits HIV Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Oral transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Sexual transmission of HIV: infectiousness and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Per-contact risk of human immunodeficiency virus transmission between male sexual partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

21 January 2018

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

Beta 2-microglobulin and immunoglobulins are more useful markers of disease progression in HIV than neopterin and adenosine deaminase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

Clinical and epidemiologic features of primary HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.8.S2.7.X

7 January 2021

10.1034/J.1601-0825.8.S2.7.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164652%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference